FRCS Revision

This site is private

Enter the password to open the revision library.

Personal revision library · not clinical advice
FRCSRevision
Home / Statistics / Metabolic and systemic bone disease
Statistics

Metabolic and systemic bone disease

Osteopetrosis, hyperparathyroidism, renal osteodystrophy and related radiographic findings.

28 questions 5 source pages 1 images 2 fact-check flags

Images appear with the first question taken from each source page — tap a question to open it.

28 questions
Q1Describe the X-ray findings in osteopetrosis.▸
  • Skeletally immature patient with generalised increased bone density
  • Canal not well seen; radiolucency at the distal femur
  • Erlenmeyer flask appearance over the distal femur
  • Dense endplate with rugger jersey appearance
  • Wormian bones; Ddx: hypoparathyroidism, pyknodysostosis, lead poisoning
Q2What is the pathophysiology of osteopetrosis?▸
  • Congenital disease causing dysfunction of the osteoclast
  • Defect in proton pump, carbonic anhydrase 2, or chloride channel
Q3What are the orthopaedic and non-orthopaedic features of osteopetrosis?▸
  • Ortho: usually asymptomatic in AD type except fracture, OA, higher risk of osteomyelitis
  • X-ray: coxa vara due to repeated fracture, bone-in-bone appearance, Erlenmeyer flask, rugger jersey spine
  • Non ortho: blindness/ deafness in AR type, anemia, cranial nerve dysfunction
  • Bloods usually normal (AR type may show increased acid phosphatase/PTH)
Q4What is the treatment of osteopetrosis?▸
  • AR: bone marrow transplant, high-dose vitamin D
  • AD: interferon gamma-1b (interferon gamma -1 beta) (Key et al NEJM 1995)
  • Surgery for proximal femur fracture: use a plate (marrow space obliterated)
Q5What is the histology of osteopetrosis?▸
  • Osteoclasts lack a ruffle border and clear zone
  • Empty lacunae
  • Plugging of the haversian canals
Q6What are the types of osteopetrosis?▸
  • Malignant (severe): AR, may be fatal in childhood without transfusion
  • Intermediate: AR, can survive to adulthood
  • Benign (mild): AD, most common, 2 types
  • Type I: no increased fracture risk
  • Type II (Albers-Schonberg disease): anaemia, pathological fractures, premature osteoarthritis; first presentation is fracture
Q7What are the X-ray features of hyperparathyroidism?▸
  • Metastatic calcification: nephrocalcinosis, lungs, blood vessels, synovium/chondrocalcinosis, calcinosis cutis
  • Subperiosteal resorption: salt and pepper skull, middle phalanx and ulna (increased concavity)
  • Brown tumour (osteitis fibrosa cystica): lytic and expansile
  • Rugger jersey spine with sclerotic endplates
Q8What is the clinical presentation of hyperparathyroidism?▸
  • Bones, groans, stones, psychic moans
  • PE: signs of CKD (oedema, cafe au lait appearance), vitamin D deficiency, renal transplant scar/RLQ mass
Q9What is a brown tumour?▸
  • Osteitis fibrosa cystica
  • Lytic and expansile; rapid bone loss -> hypervascular granulation -> fibrous tissue
  • Histology = GCT
  • Other Ddx: metastasis, multiple myeloma, GCT/ABC
Q10What is the histology and management of hyperparathyroidism?▸
  • Focal area of increased osteoclasts amidst fibrous stroma
  • Peripheral rim of osteoid
  • Treat the underlying cause (parathyroidectomy / renal replacement therapy)
Q11What is metastatic calcification in hyperparathyroidism?▸
  • Calcification in normal soft tissue due to a local increase in calcium -> calcium phosphate deposition
  • Sites: nephrocalcinosis, lungs, blood vessels, synovium/chondrocalcinosis, calcinosis cutis
Q12What is renal osteodystrophy and what are the XR findings?📷▸
Renal osteodystrophy
Renal osteodystrophy
  • Failure of bone mineralisation due to chronic renal failure
  • XR: brown tumour and looser zone at the compression side
Q13What is the pathophysiology of low-turnover renal osteodystrophy?▸
  • Aluminium toxicity
  • Decreases PTH release
  • Decreases osteoblast differentiation and proliferation
  • Decreased mineralisation -> osteomalacia (adynamic bone secondary to Al toxicity)
Q14What other bone disease occurs in chronic renal failure?▸
  • Osteoporosis
  • Amyloid bone disease: B2 macroglobulin deposits in the juxta-articular region, especially ball-and-socket joints
  • XR: bone cyst with sclerotic edge causing erosive arthritis
  • Other sites: carpal tunnel syndrome + carpal cyst
Q15What is the pathophysiology of high-turnover renal osteodystrophy?▸
  • Phosphate retention increases PTH by 3 mechanisms
  • 1. Direct decrease in serum calcium, stimulating PTH
  • 2. Decrease in renal 1-alpha hydroxylation -> less serum calcium
  • 3. Direct increase in synthesis of PTH
  • Secondary hyperPTH raises serum Ca, which binds phosphate -> ectopic calcification
Q16Describe the imaging findings of loose bodies in the elbow.▸
  • Well-circumscribed radio-opacity
  • Clustered ossification/calcification
  • Mainly over the anterior elbow, also around the trochlear groove
  • Minimal OA; no varus/valgus malalignment; no stippled calcification
Q17What is the clinical presentation and what is it associated with?▸
  • Age 30-40 years
  • Pain, loose body sensation, locking
  • Association: OA, OCD, osteochondroma
Q18What is the pathogenesis of loose bodies?▸
  • Synovial cell metaplasia into chondrocytes (primary spontaneous; secondary incited by loose bodies)
  • Nutrition from synovial fluid
  • Cartilage shell: increased nourishment -> increase in size
  • Calcified core: decreased nourishment, apoptosis, calcium salt remains
Q19What is the classification of loose bodies?▸
  • Primary: synovial metaplasia; XR smaller, similar in size
  • Secondary: OCD, OA, AVN, osteochondroma; XR larger, varied
Q20What are the phases of synovial osteochondromatosis?▸
  • Phase 1: active synovitis without loose bodies
  • Phase 2: nodular synovitis along with loose bodies
  • Phase 3: loose bodies present with resolution of synovitis
Q21What are the MRI findings and management of loose bodies?▸
  • Cartilage shell: decrease T1, increase T2
  • No cartilage shell: decrease in both T1 and T2
  • Mx: symptom relief, prevent secondary OA
  • Synovectomy + removal of loose bodies
Q22What are the three main categories of soft tissue calcification?▸
  • Dystrophic
  • Metastatic
  • Calcinosis (cutaneous, subcutaneous, deep connective tissue)
Q23What are the causes of dystrophic soft tissue calcification?▸
  • Vascular: phlebolith
  • Infection: TB
  • Tumour: synovial sarcoma, osteosarcoma, chondrosarcoma, synovial chondromatosis, haemangioma
  • Haematoma
  • Calcific tendinitis
Q24What are the types and causes of metastatic soft tissue calcification?▸
  • Increased calcium - hyperPTH
  • Increased phosphate - CKD
  • Gout
  • May resemble tumoral calcinosis
Q25How is calcinosis classified by extent?▸
  • Focal: hand - calcinosis circumscripta; joint - chondrocalcinosis, tumoral calcinosis
  • Diffuse: calcinosis universalis, myositis ossificans progressiva
Q26Where can calcinosis be deposited anatomically?▸
  • Cutaneous
  • Subcutaneous
  • Deep connective tissue
Q27What are the radiological features of tumoral calcinosis?▸
  • Amorphous, lobulated
  • Chicken-wire lucencies (thin fibrous septae)
  • Cobblestone appearance
  • Cystic lesions with fluid level = calcium hydroxyapatite precipitation
Q28What is calcinosis circumscripta and how does it present clinically?▸
  • Well defined subcutaneous nodules
  • Ulcerating with chalky hydroxyapatite discharge

Fact check

Intermediate osteopetrosis is autosomal recessive and is called Albers-Schonberg disease — Misleading / internally contradictory — Albers-Schonberg disease is the autosomal dominant type II (mild) form, as the same page later states; intermediate osteopetrosis can be AR or AD — source
Autosomal dominant osteopetrosis is treated with interferon gamma-1b (Key et al NEJM 1995) — Misleading - Key 1995 studied severe infantile (recessive) disease — IFN-gamma-1b is FDA approved for severe malignant osteopetrosis (autosomal recessive), often as a bridge to HSCT; evidence in ADO is insufficient and it was poorly tolerated — source